Rubra Medicaments reports standalone net profit of Rs 0.01 crore in the September 2021 quarter
Sales rise 188.89% to Rs 0.26 crore
Net profit of Rubra Medicaments remain constant at Rs 0.01 crore in the quarter ended September 2021 and also during the previous quarter ended September 2020. Sales rose 188.89% to Rs 0.26 crore in the quarter ended September 2021 as against Rs 0.09 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales0.260.09 189 OPM %7.6911.11 -PBDT0.020.01 100 PBT0.020.01 100 NP0.010.01 0Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 12 2021 | 2:49 PM IST